Amedisys(AMED)
搜索文档
Amedisys(AMED) - 2019 Q4 - Earnings Call Transcript
2020-02-20 08:19
Amedisys, Inc. (NASDAQ:AMED) Q4 2019 Earnings Conference Call February 19, 2020 11:00 AM ET Company Participants Nick Muscato - Vice President of Strategic Finance Paul Kusserow - Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Dave Kemmerly - General Counsel and SVP of Government Affairs Conference Call Participants Brian Tanquilut - Jefferies Matt Larew - William Blair David MacDonald - SunTrust Frank Morgan - RBC Capital Markets A.J. Rice - Credit Suiss ...
Amedisys(AMED) - 2019 Q4 - Annual Report
2020-02-19 22:39
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-24260 AMEDISYS, INC. (Exact Name of Registrant as Specified in its Charter) | --- | --- | --- | |------------------------------------ ...
Amedisys(AMED) - 2019 Q3 - Earnings Call Transcript
2019-10-31 05:51
Amedisys, Inc. (NASDAQ:AMED) Q3 2019 Earnings Conference Call October 30, 2019 11:00 AM ET Company Participants Nick Muscato - Vice President of Strategic Finance Paul Kusserow - Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Conference Call Participants Brian Tanquilut - Jefferies Matthew Larew - William Blair Justin Bowers - Deutsche Bank Joanna Gajuk - Bank of America John Ransom - Raymond James Kevin Ellich - Craig Hallum Matthew Gillmor - Robert Bair ...
Amedisys(AMED) - 2019 Q3 - Quarterly Report
2019-10-30 20:24
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share AMED The NASDAQ Global Select Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr ...
Amedisys(AMED) - 2019 Q2 - Earnings Call Transcript
2019-08-02 06:18
Amedisys, Inc. (NASDAQ:AMED) Q2 2019 Earnings Conference Call August 1, 2019 11:00 AM ET Company Participants Nick Muscato - VP, Strategic Finance Paul Kusserow - President & CEO Scott Ginn - CFO Chris Gerard - COO Dave Kemmerly - General Counsel & SVP, Government Affairs Conference Call Participants Brian Tanquilut - Jefferies Matt Larew - William Blair Matthew Gillmor - Robert Baird John Ransom - Raymond James Kevin Ellich - Craig-Hallum Joanna Gajuk - Bank of America Bill Sutherland - The Benchmark Compa ...
Amedisys(AMED) - 2019 Q2 - Quarterly Report
2019-08-01 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share AMED The NASDAQ Global Select Market FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ...
Amedisys(AMED) - 2019 Q1 - Earnings Call Transcript
2019-05-02 13:13
Amedisys, Inc. (NASDAQ:AMED) Q1 2019 Results Conference Call May 1, 2019 11:00 AM ET Company Participants Nick Muscato - Vice President of Strategic Finance Paul Kusserow - President and Chief Executive Officer Scott Ginn - Chief Financial Officer Chris Gerard - Chief Operating Officer Dave Kemmerly - General Counsel and Vice President of Government Affairs Conference Call Participants Jason Plagman - Jefferies Matt Larew - William Blair Joanna Gajuk - Bank of America Matthew Gillmor - Robert Baird Kevin El ...